Barclays’s Alvotech ALVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$89.9K Buy
24,357
+525
+2% +$1.88K ﹤0.01% 4089
2026
Q1
$81.7K Buy
23,832
+8,373
+54% +$36.8K ﹤0.01% 4112
2025
Q4
$79.3K Sell
15,459
-5,745
-27% -$36.3K ﹤0.01% 4642
2025
Q3
$174K Buy
21,204
+180
+0.9% +$1.53K ﹤0.01% 4397
2025
Q2
$192K Sell
21,024
-1,643
-7% -$15.4K ﹤0.01% 4310
2025
Q1
$219K Buy
22,667
+6,807
+43% +$82.6K ﹤0.01% 3994
2024
Q4
$210K Buy
+15,860
New +$195K ﹤0.01% 4285
2022
Q3
Sell
-1,256
Closed -$10K 4759
2022
Q2
$10K Buy
+1,256
New +$11.7K ﹤0.01% 4613

Other funds holding ALVO

Barclays's ALVO Position: Q2 2026 in Review

Barclays increased its Alvotech (ALVO) stake by 2.2% in Q2 2026, buying an estimated $1.88K and bringing the position to 24,357 shares worth $89.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4089.

Barclays first reported a position in ALVO in Q2 2022 and has held it in 8 quarters since. The position peaked at $219K in Q1 2025. 72 funds tracked by Wall St. Rank hold ALVO as of Q2 2026.

  • Barclays held 24,357 shares of Alvotech worth $89.9K as of Q2 2026.
  • Barclays bought 525 Alvotech shares in Q2 2026, an estimated $1.88K.
  • Alvotech made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4089 holding.
  • Barclays first reported a position in Alvotech in Q2 2022 and has held it in 8 quarters since.
  • Barclays's Alvotech position peaked at $219K in Q1 2025.
  • 72 funds tracked by Wall St. Rank held Alvotech as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.